Rhythm Pharmaceuticals
RYTM
RYTM
111 hedge funds and large institutions have $563M invested in Rhythm Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 32 increasing their positions, 37 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.68% more ownership
Funds ownership: 96.39% → 97.07% (+0.68%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
14% less repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 37
Holders
111
Holding in Top 10
1
Calls
$4.23M
Puts
$272K
Top Buyers
| 1 | +$26.1M | |
| 2 | +$7.03M | |
| 3 | +$3.02M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$2.88M |
| 5 |
Goldman Sachs
New York
|
+$2.8M |
Top Sellers
| 1 | -$18.2M | |
| 2 | -$12.9M | |
| 3 | -$7.61M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$2.11M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1.24M |